文献速递头颈外科

GSTP1与ERCC1基因多态性与局部晚期头颈癌铂类放化疗毒性的关联

Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment.
PubMed 文献 · Head Neck · 2019-04-11

研究纳入110例接受顺铂为基础放化疗的局部晚期头颈鳞癌患者,对29个基因的36个单核苷酸多态性(SNP)进行基因分型,分析其与急性毒性的关联。结果发现ERCC1 rs11615-C、rs735482-C及ERCC4 rs1799801-C等位基因与较低2-3级血液学毒性风险相关,GSTP1 G等位基因与严重吞咽困难风险显著降低相关。作者认为ERCC1和GSTP1多态性可能作为放化疗急性毒性的预后因素。

要点

  • ERCC1 rs11615-C、rs735482-C及ERCC4 rs1799801-C与较低2-3级血液学毒性风险相关。
  • GSTP1 G等位基因与严重吞咽困难风险显著降低相关(P = .0004)。
  • 作者认为ERCC1和GSTP1多态性可能作为放化疗急性毒性的预后因素。

核心结论

  • ERCC1和GSTP1基因多态性可能作为头颈鳞癌患者放化疗期间急性毒性的预后因素。

研究设计与样本

  • 在110例接受顺铂为基础放化疗的局部晚期头颈鳞癌患者中,对29个基因的36个选定单核苷酸多态性(SNP)进行基因分型,DNA取自血样,采用MassARRAY iPLEX Gold(Sequenom)法分析。

主要发现

  • 携带ERCC1 rs11615-C等位基因的患者2-3级血液学毒性风险较低(P = .0066)。
  • 携带ERCC1 rs735482-C等位基因的患者2-3级血液学毒性风险较低(P = .0204)。
  • 携带ERCC4 rs1799801-C等位基因的患者2-3级血液学毒性风险较低(P = .0286)。
  • 携带GSTP1 G等位基因与严重吞咽困难风险显著降低相关(P = .0004)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Platinum-based chemoradiotherapy (CRT) is the standard treatment for locally advanced head and neck squamous-cell carcinomas (HNSCC), and most patients experience serious toxicities. The aim of this study was to investigate the association between candidate genes involved in radiation/platinum pathways and acute toxicity of CRT to determine the predictive value of these polymorphisms for toxicity. METHODS: Thirty-six selected single nucleotide polymorphisms (SNPs) in 29 genes were genotyped in 110 patients treated with cisplatin-based CRT. DNA was obtained from blood samples, and SNP analysis was performed using a MassARRAY iPLEX Gold (Sequenom) method. RESULTS: Patients with ERCC1 rs11615-C allele (P = .0066), ERCC1 rs735482-C allele (P = .0204), and ERCC4 rs1799801-C allele (P = .0286) had lower risk of grade 2-3 hematologic toxicity. In addition, the presence of G allele of GSTP1 was associated with a significantly lower risk of severe dysphagia (P = .0004). CONCLUSION: Polymorphisms in ERCC1 and GSTP1 may act as prognostic factors of acute toxicity during treatment with CRT in HNSCC patients.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Duran G, Aguín S, Cruz R, et al. Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment. Head Neck. 2019. PMID: 30973677. doi:10.1002/hed.25754

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。